Citadel Securities LLC recently announced the acquisition of new stake in China SXT Pharmaceuticals Inc (NASDAQ:SXTC). This fresh investment now brings its stake to 1.35% valued currently at $16226.0. In addition, Two Sigma Securities LLC raised its holdings by 1176.0 to 1999.0 shares.
With over 30.97 million China SXT Pharmaceuticals Inc (SXTC) shares trading Friday and a closing price of $3.97 on the day, the dollar volume was approximately $122.94 million. The shares have shown a negative half year performance of -32.43% and its price on 12/29/23 gained nearly 97.51%. Currently, there are 11.43M common shares owned by the public and among those 0.56M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Fidelity Nasdaq Composite Index F owns 54.0 shares of the company’s stock, all valued at over $114.0. The company bought an additional 1.0 shares recently to bring their total holdings to about 0.01% of the shares outstanding.
Shares of China SXT Pharmaceuticals Inc (NASDAQ: SXTC) opened at $5.86, up $3.85 from a prior closing price of $2.01. However, the script later moved the day high at 6.3900, up 97.51%. The company’s stock has a 5-day price change of 116.94% and 29.11% over the past three months. SXTC shares are trading -70.70% year to date (YTD), with the 12-month market performance down to -68.86% lower. It has a 12-month low price of $1.65 and touched a high of $17.00 over the same period. SXTC has an average intraday trading volume of 162.93K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 94.77%, 84.29%, and -6.57% respectively.
Institutional ownership of China SXT Pharmaceuticals Inc (NASDAQ: SXTC) shares accounts for 3.40% of the company’s 11.43M shares outstanding. Mutual fund holders own 0.01%, while other institutional holders and individual stakeholders account for 3.39% and — respectively.
It has a market capitalization of $2.26M and a beta (3y monthly) value of 0.82. The earnings-per-share (ttm) stands at -$0.97. Price movements for the stock have been influenced by the stock’s volatility, which stands at 23.30% over the week and 17.43% over the month.
